Peiman Hematti, MD Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
Dr. Peiman Hematti joined the Section of Hematology/Bone Marrow Transplantation at the University of Wisconsin-Madison in July 2004 as an Assistant Professor in the Department of Medicine. Dr. Hematti has completed a combined Internal Medicine/Pediatrics residency at the Cleveland Clinic Foundation and then Hematology fellowship at the National Heart, Lung and Blood Institute at the National Institutes of Health. His clinical interests are in inpatient care of hematopoietic stem cell transplant patients. He is the director of the clinical hematopoietic cell processing laboratory, and in that capacity oversees all the peripheral blood stem cell collections from the patients and processing of their products.
UW Health Clinics
UW School of Medicine and Public Health
|Department of MedicineDepartment of Pediatrics|
Professional Certifications and Education
National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD
Cleveland Clinic Foundation, OH
Cleveland Clinic Foundation, OH
Tehran University of Medical Sciences, Iran, 1990
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
Programs & Conditions
Dr. Hematti runs an active basic research lab with the goal of developing methods for ex vivo generation and expansion of hematopoietic stem cells. His clinical research interest is in using novel mobilization agents for collection of peripheral blood stem cells.
Arai S Arora M Wang T Spellman SR He W Couriel DR Urbano-Ispizua A Cutler CS Bacigalupo AA Battiwalla M Flowers ME Juckett MB Lee SJ Loren AW Klumpp TR Prockup SE Ringdén OT Savani BN Socié G Schultz KR Spitzer T Teshima T Bredeson CN Jacobsohn DA Hayashi RJ Drobyski WR Frangoul HA Akpek G Ho VT Lewis VA Gale RP Koreth J Chao NJ Aljurf MD Cooper BW Laughlin MJ Hsu JW Hematti P Verdonck LF Solh MM Norkin M Reddy V Martino R Gadalla S Goldberg JD McCarthy PL Pérez-Simón JA Khera N Lewis ID Atsuta Y Olsson RF Saber W Waller EK Blaise D Pidala JA Martin PJ Satwani P Bornhäuser M Inamoto Y Weisdorf DJ Horowitz MM Pavletic SZ .
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2015 Feb;21(2):266-74
[PubMed ID: 25445023]
Bloom DD Centanni JM Bhatia N Emler CA Drier D Leverson GE McKenna DH Jr Gee AP Lindblad R Hei DJ Hematti P .
A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression. Cytotherapy. 2015 Feb;17(2):140-51
[PubMed ID: 25455739]
Hsu JW Wingard JR Logan BR Chitphakdithai P Akpek G Anderlini P Artz AS Bredeson C Goldstein S Hale G Hematti P Joshi S Kamble RT Lazarus HM O'Donnell PV Pulsipher MA Savani BN Schears RM Shaw BE Confer DL .
Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a center for international blood and marrow transplant research analysis. Biol Blood Marrow Transplant. 2015 Jan;21(1):165-71
[PubMed ID: 25316111]
Cuiffo BG Campagne A Bell GW Lembo A Orso F Lien EC Bhasin MK Raimo M Hanson SE Marusyk A El-Ashry D Hematti P Polyak K Mechta-Grigoriou F Mariani O Volinia S Vincent-Salomon A Taverna D Karnoub AE .
MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis. Cell Stem Cell. 2014 Dec 4;15(6):762-74
[PubMed ID: 25515522]
Raval AN Schmuck EG Tefera G Leitzke C Ark CV Hei D Centanni JM de Silva R Koch J Chappell RG Hematti P .
Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial. Cytotherapy. 2014 Dec;16(12):1720-32
[PubMed ID: 25239491]
Callander N Markovina S Eickhoff J Hutson P Campbell T Hematti P Go R Hegeman R Longo W Williams E Asimakopoulos F Miyamoto S .
Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology Network. Cancer Chemother Pharmacol. 2014 Oct;74(4):875-82
[PubMed ID: 25168296]
Goodrich AD Varain NM Jeanblanc CM Colon DM Kim J Zanjani ED Hematti P .
Influence of a dual-injection regimen, plerixafor and CXCR4 on in utero hematopoietic stem cell transplantation and engraftment with use of the sheep model. Cytotherapy. 2014 Sep;16(9):1280-93
[PubMed ID: 25108653]
Hanley PJ Mei Z Durett AG Cabreira-Harrison Mda G Klis M Li W Zhao Y Yang B Parsha K Mir O Vahidy F Bloom D Rice RB Hematti P Savitz SI Gee AP .
Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System. Cytotherapy. 2014 Aug;16(8):1048-58
[PubMed ID: 24726657]
Hope C Ollar SJ Heninger E Hebron E Jensen JL Kim J Maroulakou I Miyamoto S Leith C Yang DT Callander N Hematti P Chesi M Bergsagel PL Asimakopoulos F .
TPL2 kinase regulates the inflammatory milieu of the myeloma niche. Blood. 2014 May 22;123(21):3305-15
[PubMed ID: 24723682]
King SN Hanson SE Chen X Kim J Hematti P Thibeault SL .
In vitro characterization of macrophage interaction with mesenchymal stromal cell-hyaluronan hydrogel constructs. J Biomed Mater Res A. 2014 Mar;102(3):890-902
[PubMed ID: 23564555]
Sellers SE Dumitriu B Morgan MJ Hughes WM Wu CO Raghavarchari N Yang Y Uchida N Tisdale JF An DS Chen IS Hematti P Donahue RE Larochelle A Young NS Calado RT Dunbar CE .
No impact of lentiviral transduction on hematopoietic stem/progenitor cell telomere length or gene expression in the rhesus macaque model. Mol Ther. 2014 Jan;22(1):52-8
[PubMed ID: 23863881]
Xu K Cantu DA Fu Y Kim J Zheng X Hematti P Kao WJ .
Thiol-ene Michael-type formation of gelatin/poly(ethylene glycol) biomatrices for three-dimensional mesenchymal stromal/stem cell administration to cutaneous wounds. Acta Biomater. 2013 Nov;9(11):8802-14
[PubMed ID: 23811217]
Kim J Escalante LE Dollar BA Hanson SE Hematti P .
Comparison of breast and abdominal adipose tissue mesenchymal stromal/stem cells in support of proliferation of breast cancer cells. Cancer Invest. 2013 Oct;31(8):550-4
[PubMed ID: 24020962]
Asimakopoulos F Kim J Denu RA Hope C Jensen JL Ollar SJ Hebron E Flanagan C Callander N Hematti P .
Macrophages in multiple myeloma: emerging concepts and therapeutic implications. Leuk Lymphoma. 2013 Oct;54(10):2112-21
[PubMed ID: 23432691]
Lockridge JL Zhou Y Becker YA Ma S Kenney SC Hematti P Capitini CM Burlingham WJ Gendron-Fitzpatrick A Gumperz JE .
Mice engrafted with human fetal thymic tissue and hematopoietic stem cells develop pathology resembling chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2013 Sep;19(9):1310-22
[PubMed ID: 23806772]
Hanson SE Kim J Hematti P .
Comparative analysis of adipose-derived mesenchymal stem cells isolated from abdominal and breast tissue. Aesthet Surg J. 2013 Aug 1;33(6):888-98
[PubMed ID: 23908304]
Kim J Zanjani ED Jeanblanc CM Goodrich AD Hematti P .
Generation of CD34+ cells from human embryonic stem cells using a clinically applicable methodology and engraftment in the fetal sheep model. Exp Hematol. 2013 Aug;41(8):749-758.e5
[PubMed ID: 23612043]
Hebron E Hope C Kim J Jensen JL Flanagan C Bhatia N Maroulakou I Mitsiades C Miyamoto S Callander N Hematti P Asimakopoulos F .
MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes/macrophages. Br J Haematol. 2013 Mar;160(6):779-84
[PubMed ID: 23252623]
Hematti P Kim J Stein AP Kaufman D .
Potential role of mesenchymal stromal cells in pancreatic islet transplantation. Transplant Rev (Orlando). 2013 Jan;27(1):21-9
[PubMed ID: 23290684]
King SN Hanson SE Hematti P Thibeault SL .
Current applications of mesenchymal stem cells for tissue replacement in otolaryngology-head and neck surgery. Am J Stem Cells. 2012;1(3):225-38
[PubMed ID: 23671810]